A study from a group at Harvard has evaluated the relationship between the rate of PSA decline after initiation of androgen-deprivation therapy (ADT) and overall survival (OS) in men with metastatic, hormone-sensitive prostate cancer (HSPC). … READ MORE …
Filed under: Management, Treatment | Tagged: ADT, metastatic hormone-sensitive prostate cancer, survival, time to PSA nadir | 1 Comment »
News and information provided on this site should not be used for diagnosing or treating any health problem or disease.
The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.
Blog at WordPress.com. WP Designer.
THE "NEW" PROSTATE CANCER INFOLINK